Skip to main content

Table 1 Antipsychotic WHO Anatomical Therapeutic Codes

From: Prescribing trends of antipsychotics in youth receiving income assistance: results from a retrospective population database study

ATC code

Drug name

Formulations in Canada

N05AA01

chlorpromazine

Oral

N05AA02

methotrimeprazine

Oral

N05AB02

fluphenazine

Oral & long-acting injection

N05AB03

perphenazine

Oral

N05AB06

trifluoperazine

Oral

N05AC01

peryciazine

Oral

N05AC02

thioridazine*

Oral

N05AC04

pipotiazine

Depot

N05AD01

haloperidol

Oral & long-acting injection

N05AF01

flupenthixol

Oral & long-acting injection

N05AF04

thiothixene

Oral

N05AF05

zuclopenthixol

Oral & long-acting injection

N05AG02

pimozide

Oral

N05AH01

loxapine

Oral

N05AH03

olanzapine†

Oral

N05AH04

quetiapine‡

Oral

N05AX08

risperidone‡

Oral & long-acting injection

  1. * Removed from Canadian market 2005.
  2. † Specific criteria (e.g. initiated by psychiatrist) for use must be demonstrated before Pharmacare coverage is provided.
  3. ‡ Specific criteria for Pharmacare coverage were in place until December 2003 after which it became a drug benefit without restrictions on use.
Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us